- The weight-loss jab Ozempic has been life-changing for retired library assistant Pat Guntrip, helping her lose over two stone and improve her blood sugar levels.
- However, a shortage of Ozempic has left many diabetes patients unable to access the drug, with fears that it may not be available until the end of 2024.
- The surge in demand for Ozempic and Wegovy, especially for weight loss purposes, has led to a shortage of these drugs for patients who rely on them for health reasons.
- The shortage has forced many patients to switch to other medications in the same class, potentially putting them at risk of complications and side-effects.
- Diabetes UK has called for a ban on off-label prescribing of Ozempic and similar drugs to ensure that patients who need them for diabetes can access them.
Source link
Endocrinology, Diabetes, Pharmacists, Public Health & Prevention